Christopher Elnan Kvistad

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo, Vojtěch Novotný, Christopher Elnan Kvistad et al. · The Lancet Neurology · 2017 · 468 citations

Medicine, Neurology, Cerebrovascular Surgery +10

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg et al. · The Lancet Neurology · 2022 · 205 citations

Medicine, Neurology, Good Clinical Practice +10

Recurrent ischemic stroke: Incidence, predictors, and impact on mortality

Andrej Netland Khanevski, Anna Therese Bjerkreim, Vojtěch Novotný et al. · Acta Neurologica Scandinavica · 2019 · 175 citations · Full text

Public Health, Biostatistics, Epidemiologic Methods +10

When to Screen Ischaemic Stroke Patients for Cancer

Henriette Aurora Selvik, Anna Therese Bjerkreim, Lars Thomassen et al. · Cerebrovascular Diseases · 2018 · 76 citations

Medicine, Neurology, Oncology +17

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

Nicola Logallo, Christopher Elnan Kvistad, Aliona Nacu et al. · BMC Neurology · 2014 · 58 citations · Full text

Medicine, Neurology, Pharmacotherapy +16